Alivus Life Sciences uploaded audio recording of Q4 & FY2025-26 earnings call held on May 15, 2026.
Disclosure made pursuant to SEBI Listing Regulations 30 and 46 with Part A of Schedule III.
Recording available on company website for investor access as regulatory compliance measure.
Company Secretary Rudalf Corriea submitted filing to BSE and NSE on May 15, 2026.